Cargando…

An Update on New Cholesterol Inhibitor: Bempedoic Acid

An increase in the level of cholesterol day by day is easily seen in most people just because of poor life style, food with high cholesterol, lack of physical work, etc. There are lots of molecules available, which lower down the cholesterol level. In this field a new molecule has been introduced th...

Descripción completa

Detalles Bibliográficos
Autor principal: Kulshreshtha, Mayank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413737/
https://www.ncbi.nlm.nih.gov/pubmed/34906059
http://dx.doi.org/10.2174/1573403X17666211214111658
_version_ 1784775823001124864
author Kulshreshtha, Mayank
author_facet Kulshreshtha, Mayank
author_sort Kulshreshtha, Mayank
collection PubMed
description An increase in the level of cholesterol day by day is easily seen in most people just because of poor life style, food with high cholesterol, lack of physical work, etc. There are lots of molecules available, which lower down the cholesterol level. In this field a new molecule has been introduced that is bimpedoic acid. Researches indicate that bempedoic acid has the same mechanism of action as statins, which means that it also inhibits the HMG-CoA reductase enzyme. This article is my best collection of published scientific data on bempedoic acid till now. It also includes the chemistry, pharmacodynamic and pharmacokinetic parameters of the mentioned new molecule.
format Online
Article
Text
id pubmed-9413737
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-94137372023-03-18 An Update on New Cholesterol Inhibitor: Bempedoic Acid Kulshreshtha, Mayank Curr Cardiol Rev Article An increase in the level of cholesterol day by day is easily seen in most people just because of poor life style, food with high cholesterol, lack of physical work, etc. There are lots of molecules available, which lower down the cholesterol level. In this field a new molecule has been introduced that is bimpedoic acid. Researches indicate that bempedoic acid has the same mechanism of action as statins, which means that it also inhibits the HMG-CoA reductase enzyme. This article is my best collection of published scientific data on bempedoic acid till now. It also includes the chemistry, pharmacodynamic and pharmacokinetic parameters of the mentioned new molecule. Bentham Science Publishers 2022-03-18 2022-03-18 /pmc/articles/PMC9413737/ /pubmed/34906059 http://dx.doi.org/10.2174/1573403X17666211214111658 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Kulshreshtha, Mayank
An Update on New Cholesterol Inhibitor: Bempedoic Acid
title An Update on New Cholesterol Inhibitor: Bempedoic Acid
title_full An Update on New Cholesterol Inhibitor: Bempedoic Acid
title_fullStr An Update on New Cholesterol Inhibitor: Bempedoic Acid
title_full_unstemmed An Update on New Cholesterol Inhibitor: Bempedoic Acid
title_short An Update on New Cholesterol Inhibitor: Bempedoic Acid
title_sort update on new cholesterol inhibitor: bempedoic acid
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413737/
https://www.ncbi.nlm.nih.gov/pubmed/34906059
http://dx.doi.org/10.2174/1573403X17666211214111658
work_keys_str_mv AT kulshreshthamayank anupdateonnewcholesterolinhibitorbempedoicacid
AT kulshreshthamayank updateonnewcholesterolinhibitorbempedoicacid